Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer

Summary

Jorey Chernett, who owns more than 5.5% of CVRx, is calling on the board to pursue a sale of the company to a strategic acquirer, highlighting the value proposition of the Barostim product to larger medical device companies.